 Cardiomyopathies
"Cardiomyopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Descriptor ID |
D009202
|
| MeSH Number(s) |
C14.280.238
|
| Concept/Terms |
Cardiomyopathies- Cardiomyopathies
- Cardiomyopathy
- Myocardial Diseases
- Disease, Myocardial
- Diseases, Myocardial
- Myocardial Disease
- Myocardiopathies
- Myocardiopathy
Cardiomyopathies, Secondary- Cardiomyopathies, Secondary
- Cardiomyopathy, Secondary
- Secondary Cardiomyopathies
- Secondary Cardiomyopathy
- Secondary Myocardial Diseases
- Disease, Secondary Myocardial
- Diseases, Secondary Myocardial
- Myocardial Disease, Secondary
- Secondary Myocardial Disease
- Myocardial Diseases, Secondary
Cardiomyopathies, Primary- Cardiomyopathies, Primary
- Cardiomyopathy, Primary
- Primary Cardiomyopathies
- Primary Cardiomyopathy
- Primary Myocardial Diseases
- Myocardial Diseases, Primary
- Disease, Primary Myocardial
- Diseases, Primary Myocardial
- Myocardial Disease, Primary
- Primary Myocardial Disease
|
Below are MeSH descriptors whose meaning is more general than "Cardiomyopathies".
Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathies".
This graph shows the total number of publications written about "Cardiomyopathies" by people in this website by year, and whether "Cardiomyopathies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 0 | 4 | | 1997 | 1 | 2 | 3 | | 1998 | 1 | 0 | 1 | | 1999 | 2 | 0 | 2 | | 2000 | 1 | 0 | 1 | | 2001 | 2 | 0 | 2 | | 2002 | 2 | 0 | 2 | | 2003 | 2 | 0 | 2 | | 2004 | 2 | 0 | 2 | | 2005 | 3 | 2 | 5 | | 2006 | 4 | 0 | 4 | | 2007 | 2 | 1 | 3 | | 2008 | 4 | 2 | 6 | | 2009 | 5 | 1 | 6 | | 2010 | 4 | 3 | 7 | | 2011 | 7 | 1 | 8 | | 2012 | 5 | 1 | 6 | | 2013 | 8 | 0 | 8 | | 2014 | 7 | 4 | 11 | | 2015 | 7 | 2 | 9 | | 2016 | 5 | 5 | 10 | | 2017 | 8 | 4 | 12 | | 2018 | 7 | 3 | 10 | | 2019 | 10 | 1 | 11 | | 2020 | 13 | 1 | 14 | | 2021 | 18 | 1 | 19 | | 2022 | 15 | 0 | 15 | | 2023 | 15 | 1 | 16 | | 2024 | 7 | 3 | 10 | | 2025 | 15 | 0 | 15 | | 2026 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Cardiomyopathies" by people in Profiles.
-
Sarswat N, Ambardekar AV, Alexander KM, Cuddy SA, Stern L, Poulsen SH, Tschöpe C, Sekijima Y, Sheikh FH, Griffin JM, Judge DP, Gillmore J, Masri A. Acoramidis in transthyretin amyloid cardiomyopathy: expanding evidence from ATTRibute-CM. Future Cardiol. 2026 Feb; 22(2):119-133.
-
Rosenthal DN, Amodeo A, Butterfield RJ, Butts R, Chrzanowski S, Cripe L, Day J, Davies R, Duong T, Evers P, Gambetta K, Harris R, Hayes E, Kaufman B, Lorts A, Mack G, Mackenzie SJ, Mammen P, Markham L, McAlister J, McDonald C, Nakano SJ, Nandi D, Navaratnam M, Nelson S, Parent JJ, Piccoli C, Richmond M, Rocha C, Sawnani H, Schrader R, Shell R, Shih R, Shugh S, Smart T, Soslow J, Spinner J, Taivassalo T, Tunugtla H, VanderPluym C, Veerapandiyan A, Villa C, Wittlieb-Weber C, Zafarullah M, Hollander S. Heart Transplantation and Ventricular Assist Device in Duchenne Muscular Dystrophy: A New Era. Pediatr Transplant. 2026 Jan; 30(1):e70253.
-
Bui QM, McCain J, Allen LA, Adler ED, Anderson C, Bloss C, Rabin BA, Urey MA. Living with Transthyretin amyloid cardiomyopathy from a patient perspective. BMC Cardiovasc Disord. 2025 Nov 12; 25(1):802.
-
Kittleson MM, Ambardekar AV, Cheng RK, Griffin JM, Maurer MS, Nativi-Nicolau J, Ruberg FL. Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance. J Am Coll Cardiol. 2026 Feb 10; 87(5):549-565.
-
Masri A, Judge DP, Ruberg FL, Gillmore JD, Grodin JL, Obici L, Maurer MS, Fontana M, Poulsen SH, van der Meer P, Cheng RK, Cuddy SAM, Ambardekar AV, Xiong K, Cao X, Murtagh G, Siddhanti S, Castaño A, Tamby JF, Fox JC, Alexander KM, Witteles R. Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis From ATTRibute-CM. J Am Coll Cardiol. 2026 Feb 10; 87(5):490-501.
-
Jurgens SJ, Melloni GEM, Kany S, Fabritz L, Rämö JT, Goette A, Kamanu FK, Berg DD, Magnussen C, Choi SH, Bonaca MP, Giugliano RP, Scirica BM, Wiviott SD, Bhatt DL, Steg PG, Raz I, Braunwald E, Pirruccello JP, Sabatine MS, Marston NA, Kirchhof P, Ellinor PT, Ruff CT. Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation: Results in 18,000 Clinical Trial Participants. J Am Coll Cardiol. 2025 Sep 09; 86(10):738-753.
-
Guo Z, Ataran A, Ma P, Yu W, Hajirezaei H, Valenzuela Ripoll C, Pedersen LN, Rashidi O, Chan MM, Shen M, Kelley S, Sargazi A, Ozcan M, Lotfinaghsh A, Cho Y, Diab A, Grogan F, Klaas A, Pompian A, Imam A, Lodhi R, Zelleke AB, Kovacs A, Margulies KB, Szymanski J, Sardiello M, Razani B, Asnani A, Kopecky BJ, Signore PE, Yi BA, Basson CT, Ravichandran KS, Prabhu SD, Bergom C, Schilling JD, Lavine KJ, Javaheri A. Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced Cardiomyopathy. Circulation. 2025 Sep 09; 152(10):661-681.
-
Dasgupta N, Poulsen SH, Emdin M, Ambardekar AV, Shah KB, Hennum L, Marwah R, Allison M, Shivanna P, Siddhanti S, Tamby JF, Falvey H, Grodin JL. Contemporary Oral Medication Use and Frequency in Patients with Transthyretin Amyloid Cardiomyopathy. Am J Cardiovasc Drugs. 2025 Nov; 25(6):829-839.
-
Perotto M, Paldino A, Mazzarotto F, Barbati G, Stroeks SLVM, Verdonschot JAJ, Akhtar M, Elliott P, Ochoa JP, Garcia-Pavia P, de Frutos F, Sepp R, Hategan L, Prasad S, Yazdani M, Morris-Rosendahl D, Palinkas ED, Girolami F, Olivotto I, Parikh VN, Fatkin D, Lakdawala N, McKenna WJ, Stolfo D, Gigli M, Brun F, Collesi C, Giacca M, Zacchigna S, Severini GM, Lenarduzzi S, Spedicati B, Santin A, Girotto G, Gasparini P, Taylor MRG, Mestroni L, Merlo M, Sinagra G, Dal Ferro M. Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study. JACC Heart Fail. 2025 Sep; 13(9):102529.
-
Trongtorsak A, De La Rosa Martinez J, Crawford TC, Bogun FM, Gu X, Puroll E, Ellenbogen KA, Chicos AB, Roukoz H, Zimetbaum PJ, Kalbfleisch SJ, Murgatroyd FD, Steckman DA, Rosenfeld LE, Soejima K, Bhan AK, Vedantham V, Dickfeld TL, DeLurgio DB, Platonov PG, Zipse MM, Nishiuchi S, Ortman ML, Narasimhan C, Patton KK, Rosenthal DG, Mukerji SS, Hoogendoorn JC, Zeppenfeld K, Torosoff M, Judson MA, Martin K, Madias C, Hermel M, Nour K, Torbey E, Sauer WH, Kron J. Race Comparisons in Patients With Cardiac Sarcoidosis: Insights From the Cardiac Sarcoidosis Consortium. Circ Arrhythm Electrophysiol. 2025 Jul; 18(7):e013670.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|